Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.

Dubberke ER, Reske KA, Hink T, Kwon JH, Cass C, Bongu J, Burnham CD, Henderson JP.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1330-1333. doi: 10.1017/ice.2018.225. Epub 2018 Sep 18.

PMID:
30226126
2.

Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results.

Kwon JH, Reske KA, Hink T, Burnham CA, Dubberke ER.

J Clin Microbiol. 2017 Feb;55(2):596-605. doi: 10.1128/JCM.02126-16. Epub 2016 Dec 7.

3.
4.

Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.

DiPersio JR, Varga FJ, Conwell DL, Kraft JA, Kozak KJ, Willis DH.

J Clin Microbiol. 1991 Dec;29(12):2724-30.

6.

[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].

Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.

Mikrobiyol Bul. 2011 Jan;45(1):1-10. Turkish.

PMID:
21341153
7.

Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.

Erb S, Frei R, Strandén AM, Dangel M, Tschudin-Sutter S, Widmer AF.

Clin Microbiol Infect. 2015 Nov;21(11):998.e9-998.e15. doi: 10.1016/j.cmi.2015.07.016. Epub 2015 Jul 29.

8.

High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.

Toltzis P, Nerandzic MM, Saade E, O'Riordan MA, Smathers S, Zaoutis T, Kim J, Donskey CJ.

Infect Control Hosp Epidemiol. 2012 Feb;33(2):175-9. doi: 10.1086/663706. Epub 2011 Dec 20.

PMID:
22227987
9.

Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Manabe YC, Vinetz JM, Moore RD, Merz C, Charache P, Bartlett JG.

Ann Intern Med. 1995 Dec 1;123(11):835-40.

PMID:
7486465
10.

Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.

Leber AL, Hindler JF, Kato EO, Bruckner DA, Pegues DA.

Infect Control Hosp Epidemiol. 2001 Mar;22(3):160-4.

PMID:
11310695
11.

Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Novak-Weekley SM, Marlowe EM, Miller JM, Cumpio J, Nomura JH, Vance PH, Weissfeld A.

J Clin Microbiol. 2010 Mar;48(3):889-93. doi: 10.1128/JCM.01801-09. Epub 2010 Jan 13.

12.

Detection of clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay.

Senok AC, Aldosari KM, Alowaisheq RA, Abid OA, Alsuhaibani KA, Khan MA, Somily AM.

Saudi J Gastroenterol. 2017 Jul-Aug;23(4):259-262. doi: 10.4103/sjg.SJG_80_17.

13.

Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.

Chan EL, Seales D, Drum H.

Clin Lab Sci. 2009 Spring;22(2):81-5.

PMID:
19534439
14.

Clostridium difficile stool shedding in infants hospitalized in two neonatal intensive care units is lower than previous point prevalence estimates using molecular diagnostic methods.

Hines AG, Freifeld A, Zhao X, Berry AA, Willett L, Iwen PC, Simonsen KA.

BMC Pediatr. 2018 Apr 13;18(1):137. doi: 10.1186/s12887-018-1113-z.

15.

Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.

Humphries RM, Uslan DZ, Rubin Z.

J Clin Microbiol. 2013 Mar;51(3):869-73. doi: 10.1128/JCM.02970-12. Epub 2012 Dec 26.

16.

Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.

Deshpande A, Pasupuleti V, Patel P, Ajani G, Hall G, Hu B, Jain A, Rolston DD.

Clin Gastroenterol Hepatol. 2011 Aug;9(8):665-669.e1. doi: 10.1016/j.cgh.2011.04.030. Epub 2011 May 13.

PMID:
21635969
17.

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.

Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, Trévoux A, De Barbeyrac B, Boussougant Y, Tigaud S, Tytgat F, Sédallian A, Duborgel S, Collignon A, Le Guern ME, Bernasconi P, Petit JC.

Arch Intern Med. 1996 Jul 8;156(13):1449-54.

PMID:
8678714
18.

Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm.

Zou J, Leung V, Champagne S, Hinch M, Wong A, Lloyd-Smith E, Nguyen TT, Romney MG, Sharma A, Payne M, Lowe CF.

Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2355-2359. doi: 10.1007/s10096-018-3383-7. Epub 2018 Sep 20.

PMID:
30238342
19.

Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Merz CS, Kramer C, Forman M, Gluck L, Mills K, Senft K, Steiman I, Wallace N, Charache P.

J Clin Microbiol. 1994 May;32(5):1142-7.

Supplemental Content

Support Center